Eugenia Wachters

Eugenia Wachters, MSc, MBA, is currently serving as the Chief Operating Officer at ProFactor Pharma Ltd, a biotech company developing a blood clotting factor replacement therapy for Haemophilia A. Previously, Eugenia held various leadership positions at companies such as Healx, Sanofi, Boehringer Ingelheim, and GSK. Eugenia has a background in biology and has also completed an Executive MBA program at Rotterdam School of Management, Erasmus University.